Caj Haglund
Impact in
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 0.5%
Papers in
- Oncology 136
- Pancreatic and Hepatic Oncology Research 47
- Peptidase Inhibition and Analysis 20
-
- Glycosylation and Glycoproteins Research 22
- Co-authors
- Johan Lundin (30 shared papers)Jaana Hagström (147 shared papers)Stig Nordling (38 shared papers)Ari Ristimäki (47 shared papers)Mikael Lundin (14 shared papers)Henrik Alfthan (15 shared papers)Harri Mustonen (67 shared papers)Ulf‐Håkan Stenman (28 shared papers)
- Journals
- Tumor Biology (21 papers)PLoS ONE (19 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (17 papers)British Journal of Cancer (16 papers)International Journal of Cancer (15 papers)
- Partner nations
- FinlandSwedenUnited States
In The Last Decade
Caj Haglund
355 papers receiving 11.7k citations
Caj Haglund's Hit Papers
Peers
Comparison fields: 5 of 158
- Oncology 3.5k
- Cancer Research 1.9k
- Otorhinolaryngology 459
- Pharmacology 963
- Health Informatics 79
Countries citing papers authored by Caj Haglund
This map shows the geographic impact of Caj Haglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caj Haglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caj Haglund more than expected).
Fields of papers citing papers by Caj Haglund
This network shows the impact of papers produced by Caj Haglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caj Haglund. The network helps show where Caj Haglund may publish in the future.
Co-authors
The 25 scholars most cited alongside Caj Haglund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 368 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Hit paper breakdown → | 2002 | 695 |
| 2 | 2018 | 479 | |
| 3 | 2007 | 405 | |
| 4 | 2003 | 308 | |
| 5 | 2009 | 291 | |
| 6 | 2013 | 276 | |
| 7 | 2002 | 191 | |
| 8 | 2005 | 187 | |
| 9 | 2008 | 163 | |
| 10 | 2009 | 157 | |
| 11 | Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. | 2003 | 134 |
| 12 | 2012 | 131 | |
| 13 | 2005 | 131 | |
| 14 | 2001 | 124 | |
| 15 | 2000 | 116 | |
| 16 | 2019 | 114 | |
| 17 | 2019 | 108 | |
| 18 | Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women. | 1992 | 108 |
| 19 | 2003 | 104 | |
| 20 | Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. | 1992 | 101 |
About Caj Haglund
Caj Haglund is a scholar working on Oncology, Molecular Biology, Surgery, Cancer Research and Immunology, having authored 368 papers that have together received 12.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (47 papers), Head and Neck Cancer Studies (26 papers), Neuroendocrine Tumor Research Advances (23 papers), Glycosylation and Glycoproteins Research (22 papers), Protease and Inhibitor Mechanisms (21 papers), Peptidase Inhibition and Analysis (20 papers), Immune Response and Inflammation (19 papers) and Inflammatory mediators and NSAID effects (16 papers). The work is most often cited by research in Oncology (3.5k citations), Cancer Research (1.9k citations), Otorhinolaryngology (459 citations), Pharmacology (963 citations) and Health Informatics (79 citations). Caj Haglund has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Johan Lundin, Jaana Hagström, Stig Nordling, Ari Ristimäki, Mikael Lundin, Henrik Alfthan, Harri Mustonen, Ulf‐Håkan Stenman, Michael J. Duffy and R. Lamerz. Their work appears in journals such as Tumor Biology, PLoS ONE, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, British Journal of Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.